Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease syndrome-related epidemic of Kaposi's sarcoma in East Africa

Journal of the National Cancer Institute

Volumn 91, Issue 21, 1999, Pages 1888-1889

  De Thé, Guy ^a   Bestetti, Giovanna ^a   Van Beveren, Monique ^a   Gessain, Antoine ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AFRICA; ARTICLE; CHILD; CONTROLLED STUDY; ENDEMIC DISEASE; EPIDEMIC; HERPES VIRUS INFECTION; HIGH RISK POPULATION; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; SEROPREVALENCE; TANZANIA; UGANDA;

EID: 0033520749     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.21.1888     Document Type: Article

References (16)

1. Schulz TF. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol 1998;79:1573-91.
2. Boshoff C, Weiss RA. Kaposi's sarcoma-associated herpesvirus. Adv Cancer Res 1998;75:57-86.
3. Taylor JF, Smith PG, Bull D, Pike MC. Kaposi's sarcoma in Uganda: geographic and ethnic distribution. Br J Cancer 1972;26: 483-97.
4. Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa JW. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int J Cancer 1993;54:26-36.
5. de-The G, Geser A, Day NE, Tukei PM, Williams EH, Beri DP, et al. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 1978;274:756-61.
6. Geser A, Brubaker G, Draper CC. Effect of a malaria suppression program on the incidence of African Burkitt's lymphoma. Am J Epidemiol 1989;129:740-52.
7. McHardy J, Williams EH, Geser A, de-The G, Beth E, Giraldo G. Endemic Kaposi's sarcoma: incidence and risk factors in the West Nile District of Uganda. Int J Cancer 1984; 33:203-12.
8. Chatlynne LG, Lapps W, Handy M, Huang YQ, Masood R, Hamilton AS, et al. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 1998;92:53-8.
9. Mayama S, Cuevas LE, Sheldon J, Omar OH, Smith DH, Okong P, et al. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 1998;77:817-20.
10. Olsen SJ, Chang Y, Moore PS, Biggar RJ, Melbye M. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region. Zambia in 1985. AIDS 1998;12: 1921-5.
11. Gallo RC. The enigmas of Kaposi's sarcoma. Science 1998;282:1837-9.
12. de-The G. Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited. IARC Sci Publ 1985;60: 165-76.
13. Beral V. Epidemiology of Kaposi's sarcoma. In: Beral V, Jaffe H, Weiss R, editors. Cancer survey. Cold Spring Harbor (NY): Cold Spring Harbor Press; 1991. p. 5-22.
14. Bestetti G, Renon G, Mauclere P, Ruffie A, Mbopi Keou FX, Eme D, et al. High sero-prevalence of human herpesvirus-8 in pregnant women and prostitutes from Cameroon [letter]. AIDS 1998;12:541-3.
15. Gessain A, Mauclere P, Van Beveren M, Plancoulaine S, Ayouba A, Essame-Oyono JL, et al. Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer 1999;81: 189-92.
16. Ziegler JL, Katongole-Mbidde E. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer 1996;65:200-3.